Abstract
Keloids and hypertrophic scars are red and elevated pathological inflammatory scars that are caused by aberrant wound healing after injury or irritation to the reticular dermis. These injuries include trauma, insect bite, burn, surgery, vaccination, skin piercing, acne, folliculitis, chicken pox, and herpes zoster. The importance of the reticular dermis in this pathology is demonstrated by the fact that superficial injuries that do not reach the reticular dermis will never cause keloidal or hypertrophic scarring. The aberrant wound healing of these pathological scars is characterized by continuous inflammation that is mainly found in the reticular dermis. Thus, the reticular layer of these scars contains large numbers of inflammatory cells, fibroblasts, and newly formed blood vessels along with accumulations of collagen. Increasing evidence suggests that these characteristic histological features of keloids and hypertrophic scars are driven by external and/or internal stimuli that are placed on the reticular layer during the course of wound healing. These stimuli are either delivered repeatedly or are continuously present. This prolongs and amplifies the reticular dermal inflammation, thereby preventing the orderly progression of wound healing to the maturation phase. These external and internal stimuli include multiple local, systemic, and genetic factors. The nature, strength, and duration of these stimuli ultimately shape the characteristics, quantity, and progression of keloids and hypertrophic scars. Therapies should aim to extinguish the inflammation. In severe cases, surgery followed by radiotherapy and then conservative therapies will be needed to fully eliminate the inflammation and prevent recurrence: this approach resets the skin to a state that allows scar maturation (the “Reset Concept”). At that point, aesthetic and functional reconstruction can proceed.
There are no financial disclosures to be made.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18(3):E606.
Huang C, Murphy GF, Akaishi S, Ogawa R. Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open. 2013;1(4):e25.
Huang C, Akaishi S, Hyakusoku H, Ogawa R. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings. Int Wound J. 2014;11(5):517–22.
Ogawa R. Mechanobiology of scarring. Wound Repair Regen. 2011;19(Suppl 1):s2–9.
Ogawa R, Akaishi S. Endothelial dysfunction may play a key role in keloid and hypertrophic scar pathogenesis: keloids and hypertrophic scars may be vascular disorders. Med Hypotheses. 2016;96:51–60.
Huang C, Liu L, You Z, Zhao Y, Dong J, Du Y, Ogawa R. Endothelial dysfunction and mechanobiology in pathological cutaneous scarring: lessons learned from soft tissue fibrosis. Br J Dermatol. 2017;177:1248–55.
Akaishi S, Akimoto M, Ogawa R, Hyakusoku H. The relationship between keloid growth pattern and stretching tension: visual analysis using the finite element method. Ann Plast Surg. 2008;60(4):445–51.
Ogawa R, Okai K, Tokumura F, Mori K, Ohmori Y, Huang C, Hyakusoku H, Akaishi S. The relationship between skin stretching/contraction and pathologic scarring: the important role of mechanical forces in keloid generation. Wound Repair Regen. 2012;20(2):149–57.
Moustafa MF, Abdel-Fattah MA, Abdel-Fattah DC. Presumptive evidence of the effect of pregnancy estrogens on keloid growth. Case report. Plast Reconstr Surg. 1975;56(4):450–3.
Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol. 1994;9(5):619–26.
Deitch EA, Wheelahan TM, Rose MP, Clothier J, Cotter J. Hypertrophic burn scars: analysis of variables. J Trauma. 1983;23(10):895–8.
Arima J, Huang C, Rosner B, Akaishi S, Ogawa R. Hypertension: a systemic key to understanding local keloid severity. Wound Repair Regen. 2015;23(2):213–21.
Huang C, Ogawa R. The link between hypertension and pathological scarring: does hypertension cause or promote keloid and hypertrophic scar pathogenesis? Wound Repair Regen. 2014;22(4):462–6.
Noishiki C, Takagi G, Kubota Y, Ogawa R. Endothelial dysfunction may promote keloid growth. Wound Repair Regen. 2017;25:976–83.
Quong WL, Kozai Y, Ogawa R. A case of keloids complicated by Castleman’s disease: interleukin-6 as a keloid risk factor. Plast Reconstr Surg Glob Open. 2017;5(5):e1336.
Miller MC, Nanchahal J. Advances in the modulation of cutaneous wound healing and scarring. BioDrugs. 2005;19(6):363–81.
Baisch A, Riedel F. Hyperplastic scars and keloids. Part I: basics and prevention. HNO. 2006;54(11):893–904.
Nakashima M, Chung S, Takahashi A, Kamatani N, Kawaguchi T, Tsunoda T, Hosono N, Kubo M, Nakamura Y, Zembutsu H. A genome-wide association study identifies four susceptibility loci for keloid in the Japanese population. Nat Genet. 2010;42(9):768–71.
Ogawa R, Watanabe A, Than Naing B, Sasaki M, Fujita A, Akaishi S, Hyakusoku H, Shimada T. Associations between keloid severity and single-nucleotide polymorphisms: importance of rs8032158 as a biomarker of keloid severity. J Invest Dermatol. 2014;134(7):2041–3.
Marneros AG, Norris JE, Watanabe S, Reichenberger E, Olsen BR. Genome scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11. J Invest Dermatol. 2004;122:1126–32.
Chen Y, Gao JH, Yan X, Song M, Liu XJ. Location of predisposing gene for one Han Chinese keloid pedigree. Zhonghua Zheng Xing Wai Ke Za Zhi. 2007;23:137–40.
Ogawa R. The latest in keloid and hypertrophic scar pathophysiology and treatment strategies: keloids can be treated by employing up-to-date surgical management. Plastic surgery pulse news 5. Quality Medical Publishing, Inc.: St Louis; 2013.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Ogawa, R. (2020). Local, Systemic, and Genetic Risk Factors for Keloids and Hypertrophic Scars and the Reset Concept of Pathological Scar Therapy. In: Ogawa, R. (eds) Total Scar Management. Springer, Singapore. https://doi.org/10.1007/978-981-32-9791-3_5
Download citation
DOI: https://doi.org/10.1007/978-981-32-9791-3_5
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-32-9790-6
Online ISBN: 978-981-32-9791-3
eBook Packages: MedicineMedicine (R0)